GlassScriptPhysician profile
Hassan Arif
NPI 1528391547
$30,447.73
in general payments reported to CMS, 2019-2025
86 companies · $7,413 in 2025
The $7,413 reported for 2025 was more than what 88% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,398 · 2020: $2,622 · 2021: $4,158 · 2022: $4,309 · 2023: $4,802 · 2024: $4,746 · 2025: $7,413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Consulting Fee: $3,179 · Education: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,431.44 |
| Consulting Fee | $3,178.77 |
| Education | $350.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $3,843.70 | 2019-2025 | Vyepti, Rexulti |
| Abbvie INC. | $3,831.69 | 2021-2025 | Botox, Qulipta, Ubrelvy |
| Teva Pharmaceuticals USA, INC. | $1,682.56 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Ucb, INC. | $1,541.67 | 2019-2025 | Rystiggo, Briviact |
| Biogen, INC. | $1,032.36 | 2019-2025 | Tysabri, Skyclarys, Vumerity |
| Novartis Pharmaceuticals Corporation | $960.71 | 2019-2025 | |
| Allergan, INC. | $842.69 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $782.55 | 2019-2025 | Ultomiris, Soliris |
| Grifols USA, LLC | $763.77 | 2019-2025 | Gamunex-C |
| Amgen INC. | $752.91 | 2019-2025 | Uplizna, Bkemv |
| Pfizer INC. | $702.28 | 2021-2025 | |
| Sk Life Science, INC. | $630.89 | 2020-2025 | |
| Argenx US, INC. | $623.51 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Genentech USA, INC. | $609.60 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Acadia Pharmaceuticals INC | $571.22 | 2019-2025 | Nuplazid |
Show all 86 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $560.94 | 2020-2025 | Mavenclad |
| Lilly USA, LLC | $558.84 | 2019-2025 | Amyvid, Emgality, Kisunla |
| Biohaven Pharmaceuticals, INC. | $525.74 | 2020-2021 | |
| Merz Pharmaceuticals, LLC | $474.07 | 2021-2024 | Xeomin |
| Alnylam Pharmaceuticals INC. | $469.65 | 2019-2025 | Onpattro, Amvuttra |
| Eisai INC. | $466.31 | 2021-2025 | |
| Genzyme Corporation | $411.23 | 2019-2024 | |
| Upsher-Smith Laboratories LLC | $400.29 | 2020-2023 | |
| Neurocrine Biosciences, INC. | $384.47 | 2020-2024 | Ingrezza, Ongentys |
| Tanabe Pharma America, INC. | $382.24 | 2021-2025 | Radicava |
| Biohaven Pharmaceutical Holding Company LTD. | $348.81 | 2022 | |
| Impel Pharmaceuticals INC. | $336.09 | 2022-2023 | Trudhesa |
| Amneal Pharmaceuticals LLC | $311.17 | 2019-2025 | Rytary, Crexont, Brekiya |
| Vanda Pharmaceuticals INC. | $301.54 | 2025 | Ponvory |
| Csl Behring | $291.98 | 2020-2024 | Hizentra |
| Merz North America, INC. | $279.39 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $271.43 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $248.18 | 2021-2025 | Hyqvia, Gammagard |
| Jazz Pharmaceuticals INC. | $235.15 | 2019-2025 | |
| Amylyx Pharmaceuticals, INC. | $227.87 | 2023-2024 | Relyvrio |
| Acorda Therapeutics, INC | $224.40 | 2019-2023 | Inbrija |
| Kyowa Kirin, INC. | $218.38 | 2020-2022 | |
| Celgene Corporation | $205.80 | 2021-2023 | Zeposia |
| Octapharma USA, INC. | $202.94 | 2022-2025 | Octagam Immune Globulin (Human), Panzyga |
| Janssen Biotech, INC. | $170.21 | 2025 | |
| Supernus Pharmaceuticals, INC. | $154.51 | 2019-2023 | |
| Scilex Pharmaceuticals INC. | $151.55 | 2022-2024 | Ztlido |
| Mdd US Operations, LLC | $143.19 | 2019-2020 | |
| Horizon Therapeutics Plc | $142.69 | 2022-2023 | Uplizna |
| Harmony Biosciences LLC | $142.65 | 2022-2024 | Wakix |
| Avion Pharmaceuticals | $141.43 | 2022-2023 | Dhivy |
| Avanir Pharmaceuticals, INC. | $137.04 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $130.19 | 2022-2025 | Purified Cortrophin Gel |
| Avadel Cns Pharmaceuticals, LLC | $109.57 | 2024-2025 | Lumryz |
| Adamas Pharmaceuticals, INC. | $94.49 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $90.08 | 2023-2024 | Nuedexta, Rexulti |
| Janssen Pharmaceuticals, INC | $85.90 | 2020-2023 | Ponvory |
| Banner Life Sciences, LLC | $81.88 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $78.72 | 2023-2024 | Aptiom |
| Akcea Therapeutics, INC. | $78.45 | 2019 | |
| Ge Healthcare | $78.32 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $64.00 | 2020-2022 | |
| Tersera Therapeutics LLC | $59.44 | 2025 | Quzyttir |
| Astrazeneca Pharmaceuticals LP | $57.83 | 2025 | Wainua |
| Cycle Pharmaceuticals INC | $54.57 | 2025 | Ormalvi, Tascenso Odt, Bafiertam |
| Ipsen Biopharmaceuticals, INC | $48.26 | 2021-2023 | Dysport |
| Assertio Therapeutics, INC. | $45.28 | 2020 | |
| Currax Pharmaceuticals LLC | $42.13 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $39.29 | 2021 | |
| Almatica Pharma LLC | $36.87 | 2021 | |
| Boston Scientific Corporation | $35.59 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Catalyst Pharmaceuticals, INC. | $32.96 | 2023 | Firdapse |
| Sandoz INC. | $31.90 | 2023 | |
| Mallinckrodt Enterprises LLC | $29.06 | 2019 | |
| 180 Medical, INC. | $28.74 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $28.23 | 2025 | Dojolvi |
| Averitas Pharma INC. | $27.72 | 2023 | Qutenza |
| Axsome Therapeutics, INC. | $27.29 | 2025 | Symbravo |
| Nevro Corp. | $26.60 | 2023 | Senza |
| Tg Therapeutics, INC. | $24.83 | 2023 | |
| Kedrion Biopharma, INC. | $23.81 | 2025 | Kedrab, Koate, Gammaked |
| Silk Road Medical, INC. | $19.31 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Springworks Therapeutics, INC. | $19.22 | 2025 | Gomekli |
| Abbott Laboratories | $17.81 | 2025 | Jot Dx |
| Medtronic, INC. | $17.14 | 2024 | Intellis Adaptivestim |
| Corium, LLC | $16.99 | 2022 | |
| Livanova USA, INC. | $15.89 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Ns Pharma, INC. | $15.27 | 2025 | Viltepso |
| Tonix Medicines, INC. | $15.05 | 2025 | Zembrace Symtouch |
| Vertical Pharmaceuticals, LLC | $13.61 | 2019 | |
| Aquestive Therapeutics, INC. | $13.15 | 2020 |
Drugs and devices associated with these payments
Vyepti $3,596Botox $2,458Qulipta $1,045Ubrelvy $685Gamunex-C $562Ultomiris $485Kesimpta $471Nurtec Odt $431Leqembi $389Octagam Immune Globulin (Human) $316Ponvory $315Onpattro $312Xeomin $299Rystiggo $295Vyvgart Hytrulo $286Panzyga $275Vyvgart $255Briviact $254Nuplazid $231Relyvrio $228Radicava $226Hyqvia $187Austedo Xr $187Hizentra $182Radicava Ors $174Skyclarys $165Amyvid $161Trudhesa $157Tysabri $153Zeposia $144Exservan $130Ztlido $129Duopa $128Mavenclad $128Wakix $117Lumryz $110Emgality $105Ingrezza $97.23Purified Cortrophin Gel $94.32Zembrace Symtouch $92.29Kisunla $92.11Rexulti $91.90Aptiom $78.72Rytary $77.32Tosymra $77.24Vumerity $72.91Nuedexta $69.16Ocrevus $67.99Quzyttir $59.44Ongentys $59.24Epidiolex $55.21Inbrija $49.57Ocrevus Zunovo $45.21Bafiertam $44.73Austedo $44.39Crexont $44.20Uplizna $42.54Enroute Transcarotid Neuroprotection System $38.62Ormalvi $37.84Soliris $34.96Firdapse $32.96Xywav $32.85Reyvow $31.94Paxlovid $29.82Comirnaty $29.82Amvuttra $29.08Dojolvi $28.23Qutenza $27.72Symbravo $27.29Nexviazyme $27.29Senza $26.60Briumvi $24.83Wainua $24.10Rhogam Ultra-Filtered Plus $23.81Albuked $23.81Koate $23.81Kedrab $23.81Gammaked $23.81Brekiya $20.76Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter $19.31Enroute Transcarotid Stent $19.31Gomekli $19.22Gammagard $18.26Dysport $18.21Zepbound $18.15Jot Dx $17.81Intellis Adaptivestim $17.14Tascenso Odt $16.73Dhivy $16.29Vns Therapy Sentiva Model 1000 Generator $15.89Wavewriter Alpha Prime 16 $15.32Viltepso $15.27Bkemv $13.90Vyalev $12.01
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hassan Arif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.